Download presentation
Presentation is loading. Please wait.
1
ELECTROCONVULSIVE THERAPY
2
ECT mechanism of action
Decrease of cerebral metabolism markedly in the frontal lobe Changes in NT receptors - Down regulation of postsynaptic beta adrenergic receptors Changes in second messenger systems - G-proteins - Adenylyl cyclase - Phospholipase c - calcium
3
ECT Indications MDD Severe with melancholic feature
With psychotic symptoms With suicidal thoughts and plan Refusion of eating Manic episodes Dangerous level of exhaustion severe Schizophrenia With marked positive symptoms Catatonia Pregnancy No tolerance to drugs Drug contraindications Geriatric and medically ill patients delirium
4
ECT Pretreatment Evaluations
Blood and urine chemistries CXR ECG Dental examination Brain imaging if indicated
5
ECT Premedications Muscarinic anticholinergic drugs Anesthetics
Muscle relaxants
6
ECT Bilateral or unilateral electrode placement
Inducing seizures at least 25 sec. Number of ECT treatments Maintenance treatment Contraindications Mortality
7
ECT Adverse Effects Headache Delirium Memory impairment Break teeth
Back pain Nausea, vomiting Muscle soreness
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.